Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Lancet Neurology
Bruno DuboisPhilip Scheltens

Abstract

The NINCDS-ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the prevailing diagnostic standards in research; however, they have now fallen behind the unprecedented growth of scientific knowledge. Distinctive and reliable biomarkers of AD are now available through structural MRI, molecular neuroimaging with PET, and cerebrospinal fluid analyses. This progress provides the impetus for our proposal of revised diagnostic criteria for AD. Our framework was developed to capture both the earliest stages, before full-blown dementia, as well as the full spectrum of the illness. These new criteria are centred on a clinical core of early and significant episodic memory impairment. They stipulate that there must also be at least one or more abnormal biomarkers among structural neuroimaging with MRI, molecular neuroimaging with PET, and cerebrospinal fluid analysis of amyloid beta or tau proteins. The timeliness of these criteria is highlighted by the many drugs in development that are directed at changing pathogenesis, particularly at the production and clearance of amyloid beta as well as at the hyperphosphorylation state of tau. Validation studies in existing and prospective cohorts are needed to advance these criteria a...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jul 1, 1991·Neurology·C FlickerB Reisberg
Nov 1, 1990·Archives of Neurology·J McGloneD R Evans
Feb 1, 1989·Archives of Neurology·D S Knopman, S Ryberg
Jan 1, 1968·Archives of Neurology·J J RebeizE P Richardson
Jun 1, 1982·Annals of Neurology·M M Mesulam
Aug 1, 1994·Electroencephalography and Clinical Neurophysiology·B SzeliesW D Heiss
May 1, 1994·Neurology·R C PetersenE G Tangalos
Jan 1, 1996·Neurology·M S MegaJ Gornbein
Jan 1, 1997·Neurobiology of Aging·M J De LeonH M Wisniewski
Nov 28, 1997·The British Journal of Psychiatry : the Journal of Mental Science·B SchmandJ Lindeboom
Feb 19, 1999·Lancet·M BobinskiH M Wisniewski
Apr 7, 1999·Alzheimer Disease and Associated Disorders·H TounsiB Dubois
Jan 5, 2000·The American Journal of Psychiatry·J D BremnerD S Charney
Oct 14, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·L O WahlundP Scheltens
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kooresh Shoghi-JadidJorge R Barrio
May 21, 2003·Archives of Neurology·Angela L GuillozetM Marsel Mesulam
Jul 10, 2003·Lancet Neurology·Philip ScheltensCharles De Carli
Feb 6, 2004·Journal of Psychiatric Research·Philippe FossatiJean-François Allilaire
Apr 8, 2004·Radiology·Meenal B PatwardhanOlivier T Rutschmann
Apr 14, 2004·Neurology·H FeldmanS Ferris

❮ Previous
Next ❯

Citations

Aug 11, 2010·Archives of Neurology·Geert De MeyerUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 12, 2011·Archives of Neurology·Lon S SchneiderUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 18, 2012·Archives of Neurology·Holly D SoaresUNKNOWN Biomarkers Consortium Alzheimer's Disease Plasma Proteomics Project
Dec 7, 2007·Archives of General Psychiatry·Bradford C DickersonDeborah Blacker
Aug 13, 2009·JAMA : the Journal of the American Medical Association·Catherine FéartPascale Barberger-Gateau
Jul 31, 2012·Aging Clinical and Experimental Research·Arturo ConsoliLeonardo Pantoni
Oct 22, 2008·Der Nervenarzt·M Bibl, J Wiltfang
Feb 21, 2009·Der Nervenarzt·V C BuschertK Bürger
Sep 17, 2011·Der Nervenarzt·R ZimmermannP Lewczuk
Mar 3, 2010·Neuroradiology·Josephine BarnesNick C Fox
Jul 12, 2012·Neuroradiology·Claire BoutetUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 22, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Alexander Drzezga, Alexander Kurz
Apr 18, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Angelo Del SoleGiovanni Lucignani
Jul 24, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Flavio NobiliMarco Pagani
Feb 19, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Eric GuedjMathieu Ceccaldi
Aug 8, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Silvia MorbelliFlavio Nobili
Dec 25, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Giovanni Lucignani, Robert Perneczky
Jul 28, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Igor YakushevAndreas Fellgiebel
Oct 20, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Mateen C MoghbelAbass Alavi
Nov 19, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Morten ZiebellGitte M Knudsen
Mar 5, 2009·Acta Neuropathologica·Maria ZellnerEllen Umlauf
Mar 17, 2010·Acta Neuropathologica·William T HuJohn Q Trojanowski
Apr 25, 2012·Acta Neuropathologica·Jon B ToledoJohn Q Trojanowski
Oct 9, 2013·Acta Neuropathologica·Clifford R JackVladimir Kepe
Feb 19, 2009·European Archives of Psychiatry and Clinical Neuroscience·Breno Satler DinizOrestes Vicente Forlenza
Jun 23, 2009·Journal of Neurology·Reiner KaschelSergio Della Sala
Feb 18, 2010·Journal of Neurology·Mario A ParraSergio Della Sala
Jul 16, 2010·Journal of Neurology·S GalluzziUNKNOWN Translational Outpatient Memory Clinic Working Group
Jun 28, 2011·Journal of Neurology·Daniela Galimberti, Elio Scarpini
Jun 1, 2012·Journal of Neurology·S PrioniF Girotti
Sep 27, 2012·Journal of Neurology·Simona LuzziLeandro Provinciali
Dec 18, 2012·Journal of Neurology·Federica AgostaMassimo Filippi
Apr 19, 2013·Journal of Neurology·Daniela Galimberti, Elio Scarpini
Feb 15, 2011·Brain Structure & Function·Igor YakushevAndreas Fellgiebel
Jun 15, 2011·Brain Structure & Function·Thomas Nickl-JockschatKathrin Reetz
Jun 21, 2011·Journal of Neural Transmission·Irena Rektorova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.